ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gastrointestinal Cancers: Colorectal Cancer
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1595010
This article is part of the Research TopicEnhancing outcomes in colorectal cancer: Multidisciplinary approaches to therapy and pain managementView all 8 articles
Description and Disposition of Home Patients with Colorectal Cancer Accessing a practical, complications related Medication Therapy Management Service
Provisionally accepted
- The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: To explore a practical complications related Medication Therapy Management (MTM) service for colorectal cancer patient which based on take home cancer drugs (THCDs), and minimize the occurrence of unexpected events by reducing complications and adverse reactions in home therapy.Method: A total of 144 patients with colorectal cancer (CRC) who underwent home cancer drugs treatment for the first time met the include criteria from July 1, 2023 to July 31, 2024. They were divided into control group and MTM intervention group randomly, MTM intervention group conducted with three courses of MTM intervention, and control group adapt with three times of conventional follow up. We compared patient characteristics, complications, adverse effects, and knowledge-practice-attitude (KPA) results.Results: Among them, 119 patients were enrolled. There were significant differences regard of cancer pain, insomnia, anxiety, and defecation disorder (p<0.05); Multivariate analysis results showed that pain, chemotherapy-induced nausea or vomiting (CINV), and defecation disorder were independent factors for unscheduled hospital admission (p<0.05); There were significant differences regard of adverse effects for home medication patient which include jaundice, hypo leukocytosis, limb edema, and fatigue (p<0.05); MTM intervention group showed better feedback than control group in Attitudes and practice Toward screening (p<0.05).(CRC) patients by effectively reducing the incidence of treatment-related complications, including nausea and vomiting (CINV), abdominal pain, and insomnia. Furthermore, it contributes to decreased rates of unplanned hospitalization and enhances key patient outcomes (KPA), warranting further investigation and clinical application in CRC management.
Keywords: colorectal cancer, MTM, complication, adverse effect, KPA
Received: 17 Mar 2025; Accepted: 30 Jun 2025.
Copyright: © 2025 Wang, Zhou, Li, Ou, Fei, Wu, Chen and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xiaoyan Li, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.